1. Home
  2. PLUR vs ATON Comparison

PLUR vs ATON Comparison

Compare PLUR & ATON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLUR
  • ATON
  • Stock Information
  • Founded
  • PLUR 2001
  • ATON 1973
  • Country
  • PLUR Israel
  • ATON British Virgin Islands
  • Employees
  • PLUR N/A
  • ATON N/A
  • Industry
  • PLUR Biotechnology: Biological Products (No Diagnostic Substances)
  • ATON Oil & Gas Production
  • Sector
  • PLUR Health Care
  • ATON Energy
  • Exchange
  • PLUR Nasdaq
  • ATON Nasdaq
  • Market Cap
  • PLUR 36.9M
  • ATON 37.1M
  • IPO Year
  • PLUR N/A
  • ATON N/A
  • Fundamental
  • Price
  • PLUR $3.50
  • ATON $4.76
  • Analyst Decision
  • PLUR Strong Buy
  • ATON
  • Analyst Count
  • PLUR 1
  • ATON 0
  • Target Price
  • PLUR $12.00
  • ATON N/A
  • AVG Volume (30 Days)
  • PLUR 9.2K
  • ATON 1.8M
  • Earning Date
  • PLUR 11-11-2025
  • ATON 11-25-2025
  • Dividend Yield
  • PLUR N/A
  • ATON N/A
  • EPS Growth
  • PLUR N/A
  • ATON N/A
  • EPS
  • PLUR N/A
  • ATON N/A
  • Revenue
  • PLUR $1,336,000.00
  • ATON N/A
  • Revenue This Year
  • PLUR $97.38
  • ATON N/A
  • Revenue Next Year
  • PLUR $293.97
  • ATON N/A
  • P/E Ratio
  • PLUR N/A
  • ATON N/A
  • Revenue Growth
  • PLUR 309.82
  • ATON N/A
  • 52 Week Low
  • PLUR $3.33
  • ATON $2.95
  • 52 Week High
  • PLUR $7.13
  • ATON $15.82
  • Technical
  • Relative Strength Index (RSI)
  • PLUR 33.59
  • ATON N/A
  • Support Level
  • PLUR $3.60
  • ATON N/A
  • Resistance Level
  • PLUR $4.00
  • ATON N/A
  • Average True Range (ATR)
  • PLUR 0.18
  • ATON 0.00
  • MACD
  • PLUR -0.03
  • ATON 0.00
  • Stochastic Oscillator
  • PLUR 1.17
  • ATON 0.00

About PLUR Pluri Inc.

Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.

About ATON AlphaTON Capital Corp. Common Stock

AlphaTON Capital Corp is a specialized digital asset treasury company focused on building and managing a strategic reserve of TON tokens and developing the Telegram ecosystem. The company implements a comprehensive treasury strategy that combines direct token acquisition, validator operations, and strategic ecosystem investments to generate sustainable returns for shareholders. Through its operations, it provides public market investors with institutional-grade exposure to the TON ecosystem and Telegram's billion user platform.

Share on Social Networks: